Technical Specifications
Compound Name: L-Carnitine
Quantity: 1200mg per vial
Format: Sterile injectable solution or lyophilized powder (batch dependent)
Chemical Formula: C₇H₁₅NO₃
Molecular Weight: Approximately 161.20 g/mol
Purity Standard: ≥98% (analytical verification, batch dependent)
Research Classification: Investigational biochemical compound – laboratory research use only
Injectable L-Carnitine 1200mg Canada is supplied as a research-grade preparation intended exclusively for laboratory and analytical applications. Each vial contains 1200 milligrams of L-carnitine prepared under controlled handling and quality verification standards appropriate for research material distribution.
This product is classified as an investigational research compound and is not authorized for therapeutic, diagnostic, or consumer use in Canada when supplied in research format.
Research Overview
L-carnitine is a naturally occurring quaternary ammonium compound synthesized from the amino acids lysine and methionine. It plays a central role in fatty acid metabolism by facilitating the transport of long-chain fatty acids into the mitochondrial matrix in experimental systems.
Research involving Injectable L-Carnitine 1200mg Canada typically focuses on mitochondrial bioenergetics, lipid metabolism pathways, and metabolic flux analysis in laboratory environments. Scientific literature describes L-carnitine as an essential cofactor in the carnitine shuttle system, which regulates the movement of fatty acyl groups across the mitochondrial membrane.
In cell culture and animal studies, L-carnitine levels are often evaluated in relation to fatty acid oxidation rates, acetyl-CoA metabolism, and ATP production efficiency. Researchers frequently measure acylcarnitine profiles and mitochondrial respiration parameters in controlled experimental settings.
Injectable L-Carnitine 1200mg Canada is supplied strictly for research purposes. All references to metabolic pathways reflect established biochemical principles and investigational research contexts and do not imply authorized therapeutic application of the research-grade material.
Mechanism Overview
L-carnitine functions in laboratory models as a carrier molecule in the carnitine shuttle system. Long-chain fatty acids are first converted to fatty acyl-CoA in the cytosol. Carnitine palmitoyltransferase I (CPT I) then catalyzes the formation of fatty acyl-carnitine, which is transported across the mitochondrial membrane.
Once inside the mitochondrial matrix, carnitine palmitoyltransferase II (CPT II) converts fatty acyl-carnitine back into fatty acyl-CoA, allowing beta-oxidation to proceed in experimental systems. Free L-carnitine is then recycled back to the cytosol.
Researchers studying Injectable L-Carnitine 1200mg Canada typically assess fatty acid oxidation rates, mitochondrial respiration capacity, and acylcarnitine accumulation in cell-based assays and animal models. Mechanistic descriptions are based on well-established biochemical pathways and are presented for educational purposes only.
Clinical Development Context
L-carnitine has been studied extensively in clinical research and is present in certain regulated pharmaceutical and nutritional products internationally. In Canada, specific L-carnitine formulations may be authorized under regulated medical or natural health product frameworks.
However, Injectable L-Carnitine 1200mg Canada, supplied in research-grade format, is categorized strictly as an investigational laboratory compound. It is distinct from authorized pharmaceutical preparations and is not represented as a prescription medication or consumer health product when provided as a research material.
Scientific interest in L-carnitine continues across fields such as metabolism research, exercise physiology, and mitochondrial biology.
Regulatory Status in Canada
Regulated L-carnitine products may be authorized in Canada under specific pharmaceutical or natural health product pathways.
Injectable L-Carnitine 1200mg, supplied in Canada as a research compound, is classified separately as an investigational laboratory material. It is not authorized by Health Canada for therapeutic or consumer use when provided in research format.
Handling, storage, and study of Injectable L-Carnitine 1200mg Canada must comply with applicable Canadian federal and provincial regulations governing chemical and biological research materials. Laboratories and research institutions are responsible for maintaining regulatory compliance.
Molecular and Structural Notes
L-carnitine is a small, water-soluble molecule with a quaternary ammonium group that contributes to its solubility and transport properties in biological systems. Its relatively low molecular weight of approximately 161.20 g/mol distinguishes it from peptide-based research compounds.
The stereoisomer L-carnitine is the biologically active form studied in metabolic research contexts. Analytical characterization of Injectable L-Carnitine 1200mg Canada typically involves high-performance liquid chromatography (HPLC) and spectrophotometric assays to confirm identity and purity before distribution.
The sterile solution or lyophilized format supports compound stability during storage when maintained under appropriate laboratory conditions.
Frequently Asked Questions
What is Injectable L-Carnitine 1200mg Canada studied for in research?
Injectable L-Carnitine 1200mg in Canada is being studied in laboratory settings to investigate fatty acid transport and mitochondrial energy metabolism pathways.
Is Injectable L-Carnitine approved for medical use in Canada?
Certain regulated formulations may exist, but research-grade Injectable L-Carnitine 1200mg Canada is not authorized for therapeutic or consumer use when supplied as a laboratory compound.
What type of compound is L-carnitine?
It is a naturally occurring quaternary ammonium compound involved in the transport of fatty acids into mitochondria.
Does Injectable L-Carnitine 1200mg Canada contain additives?
Unless specified in batch documentation, the vial contains only the research-grade L-carnitine compound.
Can Injectable L-Carnitine 1200mg Canada be used outside research facilities?
No. It is supplied strictly for controlled laboratory and analytical research purposes.
Educational Disclaimer
Injectable L-Carnitine 1200mg Canada is an investigational research compound supplied solely for laboratory and analytical use. It is not approved by Health Canada as a medication, therapeutic agent, or consumer product when provided in research-grade form.
Information provided on this page is educational in nature and based on publicly available scientific literature describing biochemical and investigational research contexts. No medical, diagnostic, or therapeutic claims are made.
Study and handling of Injectable L-Carnitine 1200mg Canada should occur only within properly equipped research facilities and in accordance with applicable Canadian regulations and institutional guidelines.
Reviews
There are no reviews yet